These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24080480)

  • 1. Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells.
    Alessio M; Zanellato I; Bonarrigo I; Gabano E; Ravera M; Osella D
    J Inorg Biochem; 2013 Dec; 129():52-7. PubMed ID: 24080480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin.
    Ravera M; Gabano E; Zanellato I; Bonarrigo I; Escribano E; Moreno V; Font-Bardia M; Calvet T; Osella D
    Dalton Trans; 2012 Mar; 41(11):3313-20. PubMed ID: 22286213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of platinum-ethacrynic acid conjugates in the treatment of mesothelioma.
    Zanellato I; Bonarrigo I; Sardi M; Alessio M; Gabano E; Ravera M; Osella D
    ChemMedChem; 2011 Dec; 6(12):2287-93. PubMed ID: 22025407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.
    Gabano E; Ravera M; Zanellato I; Tinello S; Gallina A; Rangone B; Gandin V; Marzano C; Bottone MG; Osella D
    Dalton Trans; 2017 Oct; 46(41):14174-14185. PubMed ID: 28984330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
    Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
    Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity.
    Griffith DM; Duff B; Suponitsky KY; Kavanagh K; Morgan MP; Egan D; Marmion CJ
    J Inorg Biochem; 2011 Jun; 105(6):793-9. PubMed ID: 21497577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.
    Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
    Biochem Pharmacol; 2015 Jun; 95(3):133-44. PubMed ID: 25888926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands.
    Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
    J Inorg Biochem; 2014 Nov; 140():72-9. PubMed ID: 25063910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum-bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis.
    Margiotta N; Ostuni R; Piccinonna S; Natile G; Zanellato I; Boidi CD; Bonarrigo I; Osella D
    J Inorg Biochem; 2011 Apr; 105(4):548-57. PubMed ID: 21334282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuable insight into the anticancer activity of the platinum-histone deacetylase inhibitor conjugate, cis-[Pt(NH3)2malSAHA-2H)].
    Brabec V; Griffith DM; Kisova A; Kostrhunova H; Zerzankova L; Marmion CJ; Kasparkova J
    Mol Pharm; 2012 Jul; 9(7):1990-9. PubMed ID: 22591133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
    Westendorf AF; Bodtke A; Bednarski PJ
    Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsymmetric Cisplatin-Based Pt(IV) Conjugates Containing a PARP-1 Inhibitor Pharmacophore Tested on Malignant Pleural Mesothelioma Cell Lines.
    Gabano E; Pinton G; Balzano C; Boumya S; Osella D; Moro L; Ravera M
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
    Hartman ML; Esposito JM; Yeap BY; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1233-40. PubMed ID: 19853261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be?
    Zanellato I; Bonarrigo I; Colangelo D; Gabano E; Ravera M; Alessio M; Osella D
    J Inorg Biochem; 2014 Nov; 140():219-27. PubMed ID: 25171667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells.
    Chen CK; Zhang JZ; Aitken JB; Hambley TW
    J Med Chem; 2013 Nov; 56(21):8757-64. PubMed ID: 24107138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates.
    Novohradsky V; Zanellato I; Marzano C; Pracharova J; Kasparkova J; Gibson D; Gandin V; Osella D; Brabec V
    Sci Rep; 2017 Jun; 7(1):3751. PubMed ID: 28623355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of citrate on malignant pleural mesothelioma cells: a synergistic effect with cisplatin.
    Zhang X; Varin E; Allouche S; Lu Y; Poulain L; Icard P
    Anticancer Res; 2009 Apr; 29(4):1249-54. PubMed ID: 19414371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.